1: Li W, Du L, Ma Y, Tang H. Successful recovery from acute-on-chronic liver failure due to acute hepatitis E virus superinfection in chronic hepatitis B: A case report. IDCases. 2024 Aug 27;37:e02069. doi: 10.1016/j.idcr.2024.e02069. PMID: 39281308; PMCID: PMC11401153.
2: Zou Y, Peng P, Zou H, Zhang Y, Chen C, Huang S. Transport and retention of COVID-19-related antiviral drugs in saturated porous media under various hydrochemical conditions. Ecotoxicol Environ Saf. 2024 Sep 12;285:117028. doi: 10.1016/j.ecoenv.2024.117028. Epub ahead of print. PMID: 39276648.
3: Jena NR, Shukla PK. Hydroxyl radical-induced C1'-H abstraction reaction of different artificial nucleotides. J Mol Model. 2024 Sep 13;30(10):330. doi: 10.1007/s00894-024-06126-5. PMID: 39269493.
4: Hashemi M, Zabihian A, Hajsaeedi M, Hooshmand M. Antivirals for monkeypox virus: Proposing an effective machine/deep learning framework. PLoS One. 2024 Sep 12;19(9):e0299342. doi: 10.1371/journal.pone.0299342. PMID: 39264896.
5: Ali Naghian AH, Hashemi Z, Chekin F, Saleh N. An ordered mesoporous carbon- silica hybrid for the detection of the antiviral drug ribavirin in clinical samples. Nanoscale Adv. 2024 Jul 29;6(18):4657-4663. doi: 10.1039/d4na00435c. PMID: 39263401; PMCID: PMC11385257.
6: Mäkinen JJ, Rosenqvist P, Virta P, Metsä-Ketelä M, Belogurov GA. Probing the nucleobase selectivity of RNA polymerases with dual-coding substrates. J Biol Chem. 2024 Sep 9:107755. doi: 10.1016/j.jbc.2024.107755. Epub ahead of print. PMID: 39260691.
7: Barboza MGL, Dyna AL, Lima TF, Tavares ER, Yamada-Ogatta SF, Deduch F, Orsato A, Toledo KA, Cunha AP, Ricardo NMPS, Galhardi LCF. In vitro antiviral effect of sulfated pectin from Mangifera indica against the infection of the viral agent of childhood bronchiolitis (Respiratory Syncytial Virus - RSV). Int J Biol Macromol. 2024 Sep 10:135387. doi: 10.1016/j.ijbiomac.2024.135387. Epub ahead of print. PMID: 39260645.
8: Liang Y, Quan X, Gu R, Meng Z, Gan H, Wu Z, Sun Y, Pan H, Han P, Liu S, Dou G. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action. Heliyon. 2024 Aug 11;10(16):e35988. doi: 10.1016/j.heliyon.2024.e35988. PMID: 39247343; PMCID: PMC11379597.
9: Mawazi SM, Fathima N, Mahmood S, Al-Mahmood SMA. Antiviral therapy for COVID-19 virus: A narrative review and bibliometric analysis. Am J Emerg Med. 2024 Sep 4;85:98-107. doi: 10.1016/j.ajem.2024.09.001. Epub ahead of print. PMID: 39244809.
10: Do TND, Abdelnabi R, Boda B, Constant S, Neyts J, Jochmans D. The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model. Antiviral Res. 2024 Sep 3;231:105994. doi: 10.1016/j.antiviral.2024.105994. Epub ahead of print. PMID: 39237005.
11: Majidifar S, Zabihian A, Hooshmand M. Combination therapy synergism prediction for virus treatment using machine learning models. PLoS One. 2024 Sep 4;19(9):e0309733. doi: 10.1371/journal.pone.0309733. PMID: 39231124; PMCID: PMC11373828.
12: Srivastava S, Kumar S, Sharma PK, Rustagi S, Mohanty A, Donovan S, Henao- Martinez AF, Sah R, Franco-Paredes C. Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management. Health Sci Rep. 2024 Sep 2;7(9):e70053. doi: 10.1002/hsr2.70053. PMID: 39229478; PMCID: PMC11368823.
13: Liu Y, Wang M, Yu N, Zhao W, Wang P, Zhang H, Sun W, Jin N, Lu H. Trends and insights in dengue virus research globally: a bibliometric analysis (1995-2023). J Transl Med. 2024 Sep 3;22(1):818. doi: 10.1186/s12967-024-05561-5. PMID: 39227968; PMCID: PMC11370300.
14: Guo X, Zhang P, Chen M, Li T, Hou C, Que X, Xu L, Zhou Z, Wang Q, Wang Z. Synthesis, structural modification, and biological activity of a novel bisindole alkaloid iheyamine A. Bioorg Chem. 2024 Aug 29;153:107757. doi: 10.1016/j.bioorg.2024.107757. Epub ahead of print. PMID: 39226649.
15: Cui P, Liu K, Yang Z, Sun P, Meng Y, Yang Q, Wu X, Lv Y, Yang Y, Wu J. Design, Synthesis, and Antiviral and Fungicidal Activities of 4-Oxo-4H-quinolin-1-yl Acylhydrazone Derivatives. ACS Omega. 2024 Aug 14;9(34):36671-36681. doi: 10.1021/acsomega.4c05046. PMID: 39220544; PMCID: PMC11360041.
16: Hsieh MH, Kao TY, Hsieh TH, Kao CC, Peng CY, Lai HC, Cheng HH, Ho MW, Chi CY, Kao JT. Predictors of liver fibrosis changes assessed by paired liver biopsies in chronic hepatitis C patients treated with direct-acting antivirals. J Microbiol Immunol Infect. 2024 Aug 14:S1684-1182(24)00149-X. doi: 10.1016/j.jmii.2024.08.005. Epub ahead of print. PMID: 39216998.
17: Lee D, Mercer O, Halai V, Gill L, Macleod C, Lampejo T. Severe measles with pneumonitis in an immunocompetent adult. Clin Med (Lond). 2024 Aug 30;24(5):100239. doi: 10.1016/j.clinme.2024.100239. Epub ahead of print. PMID: 39208983.
18: Yan X, Luo C, Yang J, Wang Z, Shao Y, Wang P, Yang S, Li Y, Dai Q, Li W, Yang X, Tao H, Ren S, Li Z, Guo X, Li S, Zhu W, Luo Y, Li J, Li S, Cao R, Zhong W. Antiviral Activity of Selective Estrogen Receptor Modulators against Severe Fever with Thrombocytopenia Syndrome Virus In Vitro and In Vivo. Viruses. 2024 Aug 20;16(8):1332. doi: 10.3390/v16081332. PMID: 39205306; PMCID: PMC11360069.
19: Sun SY, Yao XX, Zhang L, Fu AS, Ge YL. Respiratory Syncytial Virus Infection in an Adult with Immunodeficiency. Clin Lab. 2024 Aug 1;70(8). doi: 10.7754/Clin.Lab.2024.240305. PMID: 39193952.
20: Mikhel I, Bakhrushina E, Stepanova O, Prilepskaya S, Kosenkov D, Belyatskaya A, Evzikov G, Demina N, Krasnyuk I Jr, Krasnyuk I. Ribavirin in Modern Antitumor Therapy: Prospects for Intranasal Administration. Curr Drug Deliv. 2024 Aug 26. doi: 10.2174/0115672018305548240614113451. Epub ahead of print. PMID: 39192644.